Fundraising Fox

Eric Huang

Investor

Partner, Ph.D. at Delos Capital

Boston, Massachusetts, United States

About

Eric Huang joined Delos Capital as a Senior Advisor in 2020, became an Operating Partner, and transitioned to full-time Partner in 2024. He previously held leadership roles at Moderna Therapeutics, including founding CSO of New Venture Labs, where he conceived the mRNA vaccine platform, and later served as GM and CSO at Moderna Genomics.

Invests in

Biotech

Experience

  1. Delos CapitalPartnercurrent2024 β€” presentBoston, Massachusetts, United States
  2. Delos CapitalOperating Partner2022 β€” 2024
  3. TAIGEN BioscienceIndependent Directorcurrent2025 β€” present
  4. TRexBioBoard Membercurrent2024 β€” presentSan Francisco Bay Area
  5. Averna TherapeuticsBoard Observercurrent2024 β€” present
  6. ModernaGM/CSO, Moderna Genomics2020 β€” 2024United States
  7. ModernaCSO, Autoimmune and Inflammation2019 β€” 2021Cambridge, Massachusetts, United States
  8. ModernaChief Scientific Officer, New Venture Labs2017 β€” 2019Cambridge, MA
  9. ModernaHead, New Venture Labs and Biologics Discovery2016 β€” 2017Cambridge MA
  10. ModernaHead, New Venture Labs2014 β€” 2017Cambridge, MA
  11. ModernaSenior Director, Strategy and Business Development2012 β€” 2014Cambridge, MA
  12. Seaside TherapeuticsDirector of Business Development2010 β€” 2012
  13. Alnylam PharmaceuticalsBusiness Development Consultant2010
  14. StromedixAssociate Director, Corporate Development and Planning2007 β€” 2010
  15. DomantisSenior Manager, Business Development2003 β€” 2007

Education

  1. New York UniversityPhD, Molecular and Medical Parasitology
  2. Questrom School of Business, Boston UniversityMBA
  3. Emory UniversityBS, Biology
  4. Bard College at Simon's Rock

Skills & more

Start-ups26Drug Discovery15Drug Development12Biotechnology30Biopharmaceuticals20New Business Development6Business Strategy6Portfolio Management5Licensing8Contract Negotiation3Infectious Diseases14Strategy12
+10 moreOncologyLife SciencesMonoclonal AntibodiesMarket ResearchPatentsMolecular BiologyPharmaceutical IndustryVenture CapitalCompetitive IntelligenceClinical Development

Languages Chinese (Mandarin)

From Eric's professional profile.

Same school

Shared employers

Colleagues at Delos Capital